Cargando…
HMGB1 promotes the development of castration-resistant prostate cancer by regulating androgen receptor activation
AR signalling pathway reactivation plays a key role in the development of castration-resistant prostate cancer (CRPC). High-mobility group protein B1 (HMGB1) is an important factor involved in the occurrence and development of a variety of tumours by regulating gene transcription. In the present stu...
Autores principales: | Chen, Junyu, Xu, Duo, Wang, Taiwei, Yang, Zhaoyun, Yang, Yanrong, He, Kang, Zhao, Lijing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9535630/ https://www.ncbi.nlm.nih.gov/pubmed/36129149 http://dx.doi.org/10.3892/or.2022.8412 |
Ejemplares similares
-
Androgen Receptor Signaling in the Development of Castration-Resistant Prostate Cancer
por: Feng, Qin, et al.
Publicado: (2019) -
Androgens as therapy for androgen receptor-positive castration-resistant prostate cancer
por: Chuu, Chih-Pin, et al.
Publicado: (2011) -
A Pegylated Liposome Loaded with Raddeanin A for Prostate Cancer Therapy
por: He, Kang, et al.
Publicado: (2023) -
Persistent androgen receptor addiction in castration-resistant prostate cancer
por: Schweizer, Michael T., et al.
Publicado: (2015) -
PRPF6 promotes androgen receptor/androgen receptor-variant 7 actions in castration-resistant prostate cancer cells
por: Liu, Wei, et al.
Publicado: (2021)